NDAINTRAMUSCULARINJECTABLE
Approved
Dec 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
6/8 — Strong
EPIPEN E Z PEN (epinephrine) by Viatris (2) is adrenergic alpha-agonists [moa]. Approved for anaphylaxis, septic shock, cardiac arrest and 2 more indications. First approved in 1987.
Drug data last refreshed Yesterday · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EpiPen EZ Pen is an intramuscular injection of epinephrine, an alpha-adrenergic agonist used for emergency treatment of anaphylaxis, septic shock, and cardiac arrhythmias. It works by stimulating adrenergic receptors to rapidly restore blood pressure, heart rate, and airway function during life-threatening allergic reactions and shock states.
LOE Approaching
EpiPen EZ Pen faces LOE pressure with moderate competitive intensity; brand defense and lifecycle management roles will dominate team activity over the next 2-3 years.
Mechanism of Action
Adrenergic alpha-Agonists
Pharmacologic Class:
alpha-Adrenergic Agonist
Indications (5)
Worked on EPIPEN E Z PEN at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.